Extensive parasite transmission and variation in a functional receptor associated with drug resistance in endemic <i>Schistosoma mansoni</i>.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 42467774.
- Also identified by DOI 10.1126/sciadv.adt3721.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Mass drug administration (MDA) with praziquantel is the cornerstone of schistosomiasis control and elimination efforts. To assess how long-term MDA affects parasite populations, we analyzed whole-genome sequence data from 570 <i>Schistosoma mansoni</i> samples and the closely related <i>Schistosoma rodhaini</i> across eight countries, combining new parasite material with publicly available sequence data. We observed a broad-scale genetic structure between countries alongside evidence of extensive long-distance transmission. Functional profiling of the recently identified transient receptor potential melastatin ion channel, <i>Sm.</i>TRPM<sub>PZQ</sub>, revealed four naturally occurring variants associated with reduced praziquantel sensitivity, indicating standing variation for resistance. Analyses of parasite infrapopulations collected from people pre- and post-praziquantel treatment further identified instances of treatment failure, supporting the potential for praziquantel resistance. As schistosomiasis is targeted for elimination as a public health problem, with interruption of transmission in selected regions by 2030, our study provides a comprehensive genomic framework for endemic populations, highlights an approach to detect potential resistance, and endorses the development of precision surveillance and adaptive treatment strategies.
Medical subject headings
- Schistosoma mansoni
- Drug Resistance
- Schistosomiasis mansoni